Skip to content

Anthropic partners with six medicine developers and starts its own drug discovery efforts

2 reports 2 reporting sources 1 hours agoNew

Understand the event

AI overview

Anthropic says its scientists have formed research partnerships with six organizations developing new medicines and have also begun their own drug discovery efforts. The partnerships have been underway for the past few months. According to Baoyu’s account of Anthropic’s announcement, Claude is being used for drug design, experiments and preparation of regulatory submission materials. That account says human clinical trials could begin as early as the end of 2028; it presents that timing as a possibility, not a confirmed start date.

Generated by AI from reports · Updated 1 hours ago

Read next

More changes in today’s briefingIntroducing GPT-6.1 Terra

Report timeline

Follow the reports to explore different sides of the event.

10/28
  1. Anthropic Details Claude’s Role in New Drug Development

    Anthropic says it has spent the past few months partnering with six organizations developing new medicines and has begun its own drug discovery efforts. The post says Claude is being used for drug design, experiments and regulatory submission materials, with human clinical trials possible as early as the end of 2028.

  2. Anthropic scientists partner with six organizations on new medicines and begin drug discovery efforts

    Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own. In doing so, we’ve learned much more about how Claude can support the many stages of

Keep up with AI, one email a day

Model releases, price changes and compute developments, with original sources. Free, confirmed by email, and easy to unsubscribe. Read a past issue

Event heat trend

There is not enough continuous observation data to plot a trend yet.